ArticleRMD open2024

Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus.

Yurie Satoh-Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.